Please use this identifier to cite or link to this item: http://adhlui.com.ui.edu.ng/jspui/handle/123456789/2171
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSALAKO, Q-
dc.contributor.authorFADIRAN, E. O-
dc.contributor.authorTHOMAS, W. O. A.-
dc.date.accessioned2024-07-17T11:44:00Z-
dc.date.available2024-07-17T11:44:00Z-
dc.date.issued1989-
dc.identifier.citationAfr. J. Med. med. Sci. (1989) 18:215-218.en_US
dc.identifier.issn1116-4077-
dc.identifier.urihttp://adhlui.com.ui.edu.ng/jspui/handle/123456789/2171-
dc.descriptionArticleen_US
dc.description.abstractSalicylic acid is a major hydrolytic degradation product of aspirin, responsible especially for gastric irritation during oral aspirin administration. This impurity was investigated in 12 different brands of aspirin formulation readily available in our locality. A simple, rapid and sensitive high performance liquid chromatographic method was adopted for this investigation. The mobile phase was methanol/water (20/80. v/v) adjusted to p|-| 2.5 with phosphoricacid and was run on a 50 mm re versed-phase column monitored at 240 nm. The limit of detection for salicylic acid was 5ng. Only three of these formulations showed the presence of salicylic acid impurity and all these contained salicylic acid in excess of the USP 1980 limit of 0.3% salicylic acid per tablet.en_US
dc.description.sponsorshipCOLLEGE OF MEDICINEen_US
dc.language.isoenen_US
dc.publisherBLACKWELL SCIENTIFIC PUBLICATIONSen_US
dc.subjectdegradation producten_US
dc.subjectaspirinen_US
dc.subjectgastric irritationen_US
dc.subjectadministrationen_US
dc.subjectformulationen_US
dc.subjectsensitive high performanceen_US
dc.titleDetection and determination of salicylic acid impurity in aspirin tablet formulations by high performance liquid chromatographyen_US
dc.typeArticleen_US
Appears in Collections:African Journal of Medicine and Medical Sciences

Files in This Item:
File Description SizeFormat 
Salako et al_Detection_1989.pdfArticle5.03 MBAdobe PDFView/Open


Items in COMUI (ADHL) are protected by copyright, with all rights reserved, unless otherwise indicated.